Insider Trading & Ownership - Harwin Peter Evan

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Harwin Peter Evan
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-09-29
Purchase
2023-10-03
4:00 pm
Dianthus Therapeutics Inc.DNTHFairmount Funds Management LLC
Kiselak Tomas
Harwin Peter Evan
Director
10% Owner
24,670$13.63$336,2521,928,503
(Indirect)
View
2023-09-26
Purchase
2023-09-28
5:09 pm
Dianthus Therapeutics Inc.DNTHFairmount Funds Management LLC
Kiselak Tomas
Harwin Peter Evan
Director
10% Owner
30,000$13.15$394,5001,903,833
(Indirect)
View
2023-09-19
Purchase
2023-09-21
4:23 pm
Dianthus Therapeutics Inc.DNTHFairmount Funds Management LLC
Kiselak Tomas
Harwin Peter Evan
Director
10% Owner
30,000$13.2$396,0001,873,833
(Indirect)
View
2023-09-12
Purchase
2023-09-13
9:17 pm
Dianthus Therapeutics Inc.DNTHFairmount Funds Management LLC
Kiselak Tomas
Harwin Peter Evan
Director
10% Owner
24,254$11.2$271,6801,850,333
(Indirect)
View
2023-07-13
Purchase
2023-07-17
8:00 pm
Apogee Therapeutics Inc.APGEFairmount Funds Management LLC
Fairmount Healthcare Fund L.P.
Fairmount Healthcare Fund II L.P.
Fairmount Healthcare Co-Invest II L.P.
Kiselak Tomas
Harwin Peter Evan
Director
2,941,176$17$49,999,992988,045
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-06-26
Option Award
2024-06-28
4:05 pm
N/A
2034-06-26
Viridian Therapeutics Inc.VRDNHarwin Peter Evan
Director
21,000$021,000
(Indirect)
View
2024-06-05
Option Award
2024-06-13
7:11 pm
N/A
2034-06-05
Cogent Biosciences Inc.COGTHarwin Peter Evan
Director
44,700$044,700
(Direct)
View
2024-06-05
Option Award
2024-06-07
8:00 pm
N/A
2034-06-05
Apogee Therapeutics Inc.APGEFairmount Funds Management LLC
Kiselak Tomas
Harwin Peter Evan
Director
20,740$020,740
(Direct)
View
2024-05-14
Option Award
2024-05-16
4:10 pm
N/A
2034-05-14
Spyre Therapeutics Inc.SYREFairmount Funds Management LLC
Kiselak Tomas
Harwin Peter Evan
Director
22,646$022,646
(Indirect)
View
2024-04-25
Exercise
2024-04-25
4:55 pm
N/A
N/A
Spyre Therapeutics Inc.SYREFairmount Funds Management LLC
Fairmount Healthcare Fund II L.P.
Kiselak Tomas
Harwin Peter Evan
Director
3,730,672$05,176,222
(Indirect)
View
2024-03-28
Other
2024-04-01
5:44 pm
N/A
N/A
Apogee Therapeutics Inc.APGEFairmount Funds Management LLC
Fairmount Healthcare Fund L.P.
Fairmount Healthcare Fund II L.P.
Kiselak Tomas
Harwin Peter Evan
Director
498,765$09,006,126
(Indirect)
View
2024-01-29
Other
2024-01-31
4:31 pm
N/A
N/A
Apogee Therapeutics Inc.APGEFairmount Funds Management LLC
Fairmount Healthcare Fund L.P.
Fairmount Healthcare Fund II L.P.
Fairmount Healthcare Co-Invest II L.P.
Kiselak Tomas
Harwin Peter Evan
Director
943,695$01,046,027
(Indirect)
View
2024-01-22
Option Award
2024-01-24
7:02 pm
N/A
N/A
Dianthus Therapeutics Inc.DNTHFairmount Funds Management LLC
Kiselak Tomas
Harwin Peter Evan
Director
10% Owner
832,333$123,595,170
(Indirect)
View
2024-01-22
Option Award
2024-01-24
7:02 pm
N/A
N/A
Dianthus Therapeutics Inc.DNTHFairmount Funds Management LLC
Kiselak Tomas
Harwin Peter Evan
Director
10% Owner
834,334$123,595,170
(Indirect)
View
2023-12-29
Other
2023-12-29
5:00 pm
N/A
N/A
Spyre Therapeutics Inc.SYREFairmount Funds Management LLC
Fairmount Healthcare Fund L.P.
Fairmount Healthcare Fund II L.P.
Fairmount Healthcare Co-Invest L.P.
Kiselak Tomas
Harwin Peter Evan
Director
10% Owner
3,841,518$05,485,719
(Indirect)
View
2023-12-07
Option Award
2023-12-11
5:41 pm
N/A
N/A
Spyre Therapeutics Inc.SYREFairmount Funds Management LLC
Fairmount Healthcare Fund L.P.
Fairmount Healthcare Fund II L.P.
Fairmount Healthcare Co-Invest L.P.
Kiselak Tomas
Harwin Peter Evan
Director
10% Owner
16,667$60016,667
(Indirect)
View
2023-11-24
Conversion
2023-11-28
4:05 pm
N/A
N/A
Spyre Therapeutics Inc.AGLEFairmount Funds Management LLC
Fairmount Healthcare Fund L.P.
Fairmount Healthcare Fund II L.P.
Fairmount Healthcare Co-Invest L.P.
Kiselak Tomas
Harwin Peter Evan
Director
10% Owner
3,521,367$04,250,938
(Indirect)
View
2023-09-11
Option Award
2023-09-13
9:17 pm
N/A
2033-09-10
Dianthus Therapeutics Inc.DNTHFairmount Funds Management LLC
Kiselak Tomas
Harwin Peter Evan
Director
10% Owner
6,500$01,850,333
(Indirect)
View

Ownership
2023-09-13
8:55 pm
N/A
N/A
Dianthus Therapeutics Inc.DNTHFairmount Funds Management LLC
Kiselak Tomas
Harwin Peter Evan
Director
10% Owner
0$01,819,579
(Indirect)
View
2023-07-13
Option Award
2023-07-17
8:00 pm
N/A
2033-07-13
Apogee Therapeutics Inc.APGEFairmount Funds Management LLC
Fairmount Healthcare Fund L.P.
Fairmount Healthcare Fund II L.P.
Fairmount Healthcare Co-Invest II L.P.
Kiselak Tomas
Harwin Peter Evan
Director
95,516$0988,045
(Direct)
View

Ownership
2023-06-30
5:32 pm
N/A
N/A
Aeglea BioTherapeutics Inc.AGLEFairmount Funds Management LLC
Fairmount Healthcare Fund L.P.
Fairmount Healthcare Fund II L.P.
Fairmount Healthcare Co-Invest L.P.
Kiselak Tomas
Harwin Peter Evan
Director
10% Owner
0$0536,284,540
(Indirect)
View
2023-06-14
Option Award
2023-06-16
8:00 pm
N/A
2023-06-14
Viridian Therapeutics Inc.VRDNHarwin Peter Evan
Director
20,000$020,000
(Indirect)
View
2023-06-07
Option Award
2023-06-08
4:37 pm
N/A
2033-06-07
Cogent Biosciences Inc.COGTHarwin Peter Evan
Director
36,700$036,700
(Direct)
View
2022-06-08
Option Award
2022-06-10
07:30 am
N/A
2032-06-08
Viridian Therapeutics Inc.VRDNHarwin Peter Evan
Director
12,500$012,500
(Indirect)
View
2022-06-07
Option Award
2022-06-09
5:08 pm
N/A
2032-06-07
Cogent Biosciences Inc.COGTHarwin Peter Evan
Director
30,700$030,700
(Direct)
View
2021-06-03
Option Award
2021-06-16
6:26 pm
N/A
2031-06-03
Viridian Therapeutics Inc.VRDNHarwin Peter Evan
Director
12,500$012,500
(Direct)
View
2021-03-11
Option Award
2021-03-15
8:44 pm
N/A
2031-03-11
Cogent Biosciences Inc.COGTHarwin Peter Evan
Director
60,000$060,000
(Direct)
View
2021-02-04
Option Award
2021-02-08
5:40 pm
N/A
2031-02-04
Viridian Therapeutics Inc.VRDNHarwin Peter Evan
Director
25,000$025,000
(Direct)
View
2020-10-27
Option Award
2020-10-29
5:19 pm
N/A
2030-10-26
MIRAGEN THERAPEUTICS INC.MGENHarwin Peter Evan
Director
24,000$024,000
(Direct)
View
2020-08-27
Option Award
2020-08-31
1:08 pm
N/A
2030-08-27
Unum Therapeutics Inc.UMRXHarwin Peter Evan
Director
28,661$028,661
(Direct)
View